Journal of Diabetic Complications & Medicine

Supneet Sandhu

Publications

• Review Article
  Safety and Efficacy of New Oral Anticoagulants in Patients with Atrial Fibrillation: A Literature Review
  Author(s): Shweta Bhatia, Supneet Sandhu and Dharinder TayalShweta Bhatia, Supneet Sandhu and Dharinder Tayal
  
  Background: TraditionallyVitamin K antagonists (VKAs), such as warfarin, have been used to reduce the risks of stroke and systemic embolism in patients with atrial fibrillation (AF). However, they are associated with increased risk of haemorrhage. Thus, there is a need for new oral anticoagulant agents that are effective, safe, and convenient to use. Recent, observational and randomized controlled clinical trials, have examined the long-term use and efficacy of new oral anticoagulants. However, their results pertaining to important secondary efï¬�?cacy end points as well as safety outcomes were inconclusive. Aim: We, therefore, performed a systematic review to examine the long-term efï¬�?cacy and safety of the new oral anticoagulants namely; dabigatran, rivaroxaban and apixaban in patients with AF. Me.. Read More»
  DOI: 10.4172/2475-3211.1000101

  Abstract PDF